Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 2
2013 5
2014 6
2015 2
2016 1
2017 1
2021 2
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutics + diagnostics = theranostics.
Haslerud T, Revheim MR. Haslerud T, et al. Tidsskr Nor Laegeforen. 2023 Jan 9;143(1). doi: 10.4045/tidsskr.22.0776. Print 2023 Jan 17. Tidsskr Nor Laegeforen. 2023. PMID: 36655959 Free article. English, Norwegian. No abstract available.
VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia.
Austestad J, Madland TM, Sandnes M, Haslerud TM, Benneche A, Reikvam H. Austestad J, et al. Among authors: haslerud tm. Case Rep Hematol. 2023 Feb 25;2023:6551544. doi: 10.1155/2023/6551544. eCollection 2023. Case Rep Hematol. 2023. PMID: 36879894 Free PMC article.
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.
Thomsen LCV, Honoré A, Reisæter LAR, Almås B, Børretzen A, Helle SI, Førde K, Kristoffersen EK, Kaada SH, Melve GK, Haslerud TM, Biermann M, Bigalke I, Kvalheim G, Azeem W, Olsen JR, Gabriel B, Knappskog S, Halvorsen OJ, Akslen LA, Bahn D, Pantel K, Riethdorf S, Ragde H, Gjertsen BT, Øyan AM, Kalland KH, Beisland C. Thomsen LCV, et al. Among authors: haslerud tm. Cancer Immunol Immunother. 2023 Jul;72(7):2357-2373. doi: 10.1007/s00262-023-03421-7. Epub 2023 Mar 20. Cancer Immunol Immunother. 2023. PMID: 36939854 Free PMC article. Clinical Trial.
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.
Morken S, Langer SW, Sundlöv A, Vestermark LW, Ladekarl M, Hjortland GO, Svensson JB, Tabaksblat EM, Haslerud TM, Assmus J, Detlefsen S, Couvelard A, Perren A, Sorbye H. Morken S, et al. Among authors: haslerud tm. Br J Cancer. 2023 Dec;129(12):1930-1939. doi: 10.1038/s41416-023-02462-0. Epub 2023 Oct 23. Br J Cancer. 2023. PMID: 37872405 Free PMC article. Clinical Trial.
Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis.
Thunestvedt LMØ, Helgeland L, Bachmann IM, Karlsdottir Å, Haslerud TM, Reikvam H. Thunestvedt LMØ, et al. Among authors: haslerud tm. Curr Oncol. 2022 Mar 23;29(4):2193-2198. doi: 10.3390/curroncol29040178. Curr Oncol. 2022. PMID: 35448152 Free PMC article.
The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based cohort study.
Søreide JA, Kvaløy JT, Lea D, Sandvik OM, Al-Saiddi M, Haslerud TM, Garresori H, Karlsen LN, Gudlaugsson E, Søreide K. Søreide JA, et al. Among authors: haslerud tm. Cancer Rep (Hoboken). 2022 Feb;5(2):e1462. doi: 10.1002/cnr2.1462. Epub 2021 Jun 8. Cancer Rep (Hoboken). 2022. PMID: 34105314 Free PMC article.
23 results